Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$1.89 - $6.57 $97,087 - $337,494
-51,369 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$2.33 - $4.94 $1,516 - $3,215
651 Added 1.28%
51,369 $150,000
Q1 2020

May 15, 2020

SELL
$1.57 - $3.85 $351 - $862
-224 Reduced 0.44%
50,718 $130,000
Q4 2019

Feb 14, 2020

SELL
$3.09 - $4.69 $11,340 - $17,212
-3,670 Reduced 6.72%
50,942 $157,000
Q3 2019

Nov 14, 2019

BUY
$2.82 - $4.81 $73 - $125
26 Added 0.05%
54,612 $260,000
Q2 2019

Aug 13, 2019

BUY
$2.07 - $5.12 $1,121 - $2,775
542 Added 1.0%
54,586 $194,000
Q1 2019

May 17, 2019

SELL
$1.88 - $5.7 $1.74 Million - $5.29 Million
-927,935 Reduced 94.5%
54,044 $113,000
Q4 2018

Feb 14, 2019

SELL
$3.02 - $9.2 $11,657 - $35,512
-3,860 Reduced 0.39%
981,979 $3.28 Million
Q3 2018

Oct 30, 2018

BUY
$6.12 - $8.97 $6.03 Million - $8.84 Million
985,839 New
985,839 $7.83 Million

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.